硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 UPF3B 抗体对
试剂盒

人 UPF3B 抗体对

01AB02554

UPF3B regulator of nonsense mediated mRNA decay (UPF3B) is a key component of the mRNA surveillance machinery that identifies and degrades transcripts containing premature termination codons. It localizes to both the nucleus and cytoplasm, where it associates with the exon junction complex and interacts with UPF1 and UPF2 to couple translation termination with mRNA decay. UPF3B contains an RNA-recognition motif-like domain and a NOPS-L region that mediate high-affinity binding to RNA and the assembly of the NMD complex. Pathogenic variants in UPF3B are a known cause of X-linked intellectual disability, which may be accompanied by autism, epilepsy, and schizophrenia. These mutations often disrupt the interaction between UPF3B and UPF2, leading to impaired NMD efficiency and neurodevelopmental pathology.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
UPF3B
基因别名
RENT3B; UPF3X
蛋白别名
UPF3B regulator of nonsense mediated mRNA decay; UPF3B
UniProt
Q9BZI7
物种
Human

产品详情

靶点名称
UPF3B
蛋白名称
UPF3B regulator of nonsense mediated mRNA decay
蛋白别名
Regulator of nonsense transcripts 3B; Nonsense mRNA reducing factor 3B; Up-frameshift suppressor 3 homolog B; hUpf3B; Up-frameshift suppressor 3 homolog on chromosome X; hUpf3p-X
靶点基因名
UPF3B
基因别名
RENT3B; UPF3X
UniProt
Q9BZI7
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

UPF3B regulator of nonsense mediated mRNA decay (UPF3B) is a key component of the mRNA surveillance machinery that identifies and degrades transcripts containing premature termination codons. It localizes to both the nucleus and cytoplasm, where it associates with the exon junction complex and interacts with UPF1 and UPF2 to couple translation termination with mRNA decay. UPF3B contains an RNA-recognition motif-like domain and a NOPS-L region that mediate high-affinity binding to RNA and the assembly of the NMD complex. Pathogenic variants in UPF3B are a known cause of X-linked intellectual disability, which may be accompanied by autism, epilepsy, and schizophrenia. These mutations often disrupt the interaction between UPF3B and UPF2, leading to impaired NMD efficiency and neurodevelopmental pathology.